FDA.reportPublic FDA data

1.2 ML risankizumab-rzaa 150 MG/ML Prefilled Syringe [Skyrizi]

RxCUI
2723332
RxNorm name
1.2 ML risankizumab-rzaa 150 MG/ML Prefilled Syringe [Skyrizi]
Display name
1.2 ML risankizumab-rzaa 150 MG/ML Prefilled Syringe [Skyrizi]
Full name
1.2 ML risankizumab-rzaa 150 MG/ML Prefilled Syringe [Skyrizi]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761105Skyrizirisankizumab-rzaa351(a)Disc2026-06-01
761262Skyrizirisankizumab-rzaa351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SkyriziRISANKIZUMAB-RZAAAbbVie Inc.7148c8eb-b39e-e20a-6494-a6df823928582026-06-15Warnings, Adverse reactionsExact identifier
rxcui: 2723332

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7148c8eb-b39e-e20a-6494-a6df823928581.2 ML risankizumab-rzaa 150 MG/ML Prefilled Syringe [Skyrizi]SBD173These highlights do not include all the information needed to use SKYRIZI safely and effectively. See full prescribing information for SKYRIZI. SKYRIZI ® (risankizumab-rzaa) injection, for subcutaneous or intravenous use Initial U.S. Approval: 201920260319
7148c8eb-b39e-e20a-6494-a6df82392858Skyrizi 180 MG in 1.2 ML Prefilled SyringePSN173These highlights do not include all the information needed to use SKYRIZI safely and effectively. See full prescribing information for SKYRIZI. SKYRIZI ® (risankizumab-rzaa) injection, for subcutaneous or intravenous use Initial U.S. Approval: 201920260319
7148c8eb-b39e-e20a-6494-a6df82392858Skyrizi 180 MG per 1.2 ML Prefilled SyringeSY173These highlights do not include all the information needed to use SKYRIZI safely and effectively. See full prescribing information for SKYRIZI. SKYRIZI ® (risankizumab-rzaa) injection, for subcutaneous or intravenous use Initial U.S. Approval: 201920260319